XML 30 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements Of Cash Flows (USD $)
In Thousands, unless otherwise specified
 9 Months Ended 141 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2013
Cash flows from operating activities:      
Net income/(loss) for the period $ (51,448) $ (29,459) $ (151,832)
Adjustments to reconcile net income/(loss) for the period to net cash used in operations:      
Depreciation and amortization 792 391 3,190
Stock-based compensation 1,212 3,036 13,263
Gain on disposal of marketable securities 33 (145) (8,016)
Loss on extinguishment of convertible notes     1,218
Accrued interest and accretion of interest     3,519
Gain on disposal of mineral property   (1,934) (80,035)
Write-down of non-current assets 3,500   10,867
Transaction Costs     1,841
Unrealized (gain)/loss on other investments 42,775 13,184 55,791
Write down of marketable securities     959
Deferred tax (benefit)/expense (15,373) (6,276) 2
Other non-cash items 66   (2,129)
Change in working capital account items:      
Other current assets 1,491 (590) (723)
Accrued interest payable     (7,586)
Accounts payable, accrued liabilities and other (4,392) (1,402) 404
Net cash used in operating activities (21,476) (23,195) (155,009)
Cash flows from investing activities:      
Purchases of marketable securities   (138) (1,841)
Proceeds from sales of marketable securities 150 248 11,693
Acquisition of long-term investments     (3,632)
Additions to mineral property     (11,571)
Additions to plant and equipment (2,290) (861) (24,933)
Change in restricted cash 27 75 (43)
Proceeds from additional option agreement   4,500 6,740
Cash transferred to Allied Nevada Gold Corp., net of receivable     (24,517)
Net cash (used in)/provided by investing activities (2,113) 3,824 (48,104)
Cash flows from financing activities:      
Net proceeds from equity financings   14,231 161,542
Proceeds from debt financing (Note 8) 9,637   9,637
Repayment of convertible notes     (26,108)
Proceeds from exercise of warrants   1,365 40,754
Proceeds from exercise of compensation options   733 733
Proceeds from exercise of stock options   21 4,068
Issuance of convertible notes     28,345
Cash paid in lieu of capital stock issuances     (107)
Transaction costs     (1,841)
Net cash provided by financing activities 9,637 16,350 217,023
Increase/(decrease) in cash and cash equivalents (13,952) (3,021) 13,910
Decrease in cash and cash equivalents - discontinued operations     (10,255)
Net increase/(decrease) in cash and cash equivalents (13,952) (3,021) 3,655
Cash and cash equivalents, beginning of period 18,281 17,873 674
Cash and cash equivalents, end of period $ 4,329 $ 14,852 $ 4,329